Copper Tripeptide-1 for Hair Regrowth - Quick Reference Sheet
evipedia.ai
← Back

Copper Tripeptide-1 for Hair Regrowth

Created on 08/04/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 4.8 – Audit

A naturally occurring copper-carrying molecule that declines with age. Lab and animal work suggests it can wake resting hair follicles, enlarge them, and improve local blood supply, but human proof for regrowth is thin. It does not block the hormone behind pattern hair loss. Topical use is well tolerated; a low-risk, unproven add-on rather than a standalone treatment. (Full Review)

Protocol

Topical
~1% serum, 1–2×/day
Leave-on scalp serum or solution applied to the affected scalp
Delivery
Microneedling 1–few×/week
Paired with the topical to improve poor scalp penetration; or fractional laser
Positioning
Add-on, not standalone
Layered with minoxidil and, in men, an oral DHT-blocker
Time to effect
Visible change
3–4 months
Daily use before assessment, mirroring minoxidil timelines
After stopping
Gradual loss
Gains presumed maintenance-dependent; follicle returns to its untreated trajectory
Peptide half-life
Minutes
Free GHK cleared within minutes; consistency matters more than dose size

Benefits

Contraindications
  • Wilson's disease or copper-overload disorders (systemic/injectable use)
  • Known copper or peptide-excipient allergy
  • Pregnancy or breastfeeding
  • Active scalp infection or inflammation
  • Copper-lowering drugs (penicillamine, trientine) for Wilson's disease (injectable)
    •
Key Interactions
  • Topical vitamin C and direct acids (L-ascorbic acid, glycolic/salicylic acid, retinoids)
  • Concurrent hair topicals (minoxidil, topical finasteride/dutasteride)
  • High-dose oral zinc supplements
  • Microneedling/injectable delivery with anticoagulants or antiplatelets (warfarin, apixaban, clopidogrel, aspirin)
    •

Risk & Side Effects

  • Low: Scalp irritation, redness, and itching; allergic contact dermatitis and copper hypersensitivity
    •
  • Speculative: Systemic copper accumulation with injectable use; product quality and contamination; formulation incompatibility and pro-oxidant concerns
    •

Monitoring

Marker Target Why
Ferritin 40–70 ng/mL Low iron stores are a common, reversible cause of shedding
Serum copper 70–140 µg/dL Screens copper status before systemic/injectable use and for overload
Ceruloplasmin 20–35 mg/dL Copper-carrier protein; abnormal levels flag Wilson's disease or deficiency
Vitamin D (25-OH) 40–60 ng/mL Low vitamin D is associated with hair-cycle disruption
TSH 0.5–2.5 mIU/L Thyroid dysfunction is a frequent, treatable cause of hair thinning
Zinc 90–120 µg/dL Copper–zinc balance affects copper status and hair health

Cadence: Baseline before starting; for systemic/injectable use, copper status every 3–6 months; topical-only users need no ongoing bloodwork

Qualitative Assessment

  • Reduced daily shedding (fewer hairs on the pillow or in the shower)
  • Standardized before-and-after photos of the same scalp areas under the same lighting
  • Perceived changes in hair thickness, coverage, and scalp visibility
  • Tolerability signals: absence of persistent redness, itching, or rash
Not medical advice. Educational distillation of a single evidence review. Confirm any decision with a qualified clinician, especially in the presence of prescription drugs or chronic conditions.